Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHiscox Regulatory News (HSX)

Share Price Information for Hiscox (HSX)

Share Price is delayed by 15 minutes
Get Live Data
1,717.00    -37.00 (-2.11%)
Bid:
1,715.00
Ask:
1,717.00
Spread: 2.00 (0.117%)
Market Cap: £5.50b
HSX Live PriceLast checked at - London Stock Exchange

Intraday Hiscox Share Chart

Update on share repurchase programme

6 Oct 2025 07:00

RNS Number : 0841C
Hiscox Ltd
06 October 2025
 

 

Update on share repurchase programme

 

Hamilton, Bermuda (6 October 2025) - Hiscox Ltd ("Hiscox" or the "Company") today announces that, further to the share repurchase programme announced on 27 February 2025, and subsequently increased on 6 August 2025, to buy back its ordinary shares of 6.5 pence each ("Ordinary Shares") for a maximum aggregate consideration of $275 million (the "Programme"), the Company completed the initial tranche of the Programme on 3 October 2025. The Company purchased 8,161,021 Ordinary Shares between 27 February 2025 and 3 October 2025 pursuant to the agreement with Peel Hunt LLP to conduct the initial tranche of the programme up to $137.5 million (excluding expenses).

 

Having completed the initial tranche, Hiscox has entered into an agreement with Citigroup Global Markets Limited ("Citigroup") to conduct the second tranche of the Programme, commencing today and ending no later than the end of the first quarter of 2026, for a maximum aggregate consideration of $137.5 million with the Company subsequently purchasing its Ordinary Shares from Citigroup. Under this arrangement, Citigroup will act as principal.

 

Purchases under the Programme will take place in open market transactions and may be made from time to time by Citigroup, depending on market conditions, share price and trading volumes. The Programme is effected under the authority granted by shareholders at the Company's 2025 Annual General Meeting held on 15 May 2025 (and any subsequent authority), the maximum number of shares that may be repurchased under the Programme is 33,995,732 Ordinary Shares. Following the completion of tranche one, 25,834,711 Ordinary Shares can be purchased under the second tranche of the Programme. Any purchases contemplated by this announcement will be carried out on the London Stock Exchange and/or other recognised investment exchange(s). The Programme will end when the maximum aggregate consideration under the second tranche reaches $137.5 million or as otherwise terminated.

 

The Programme will continue to be conducted within the parameters prescribed by the Market Abuse Regulation 596/2014 and the Commission Delegated Regulation (EU) 2016/1052 as it forms part of UK law pursuant to the UK's European Union (Withdrawal) Act 2018 and the Market Abuse (Amendment) (EU Exit) Regulations 2019) as well as applicable laws and the regulations of the UK Financial Conduct Authority (including Chapter 12 of the Listing Rules).

 

The purpose of the Programme is to reduce the issued share capital of the Company. The purchased Ordinary Shares will be cancelled.

 

Any repurchase of shares will be announced no later than 7:30 a.m. on the business day following the calendar day on which the repurchase occurred.

 

There is no guarantee that the Programme will be implemented in full.

 

ENDS

 

 

For further information

Investors and analysts

Yana O'Sullivan, Director of Investor Relations, London +44 (0)20 3321 5598

Marc Wetherhill, Group Company Secretary, Bermuda +1 441 278 8300

 

Media

Eleanor Orebi Gann, Group Director of Communications, London +44 (0)20 7081 4815

Simone Selzer, Brunswick +44 (0)20 7404 5959

Tom Burns, Brunswick +44 (0)20 7404 5959

Notes to editors

About The Hiscox Group

Hiscox is a global specialist insurer, headquartered in Bermuda and listed on the London Stock Exchange (LSE:HSX). Our ambition is to be a respected specialist insurer with a diverse portfolio by product and geography. We believe that building balance between catastrophe-exposed business and less volatile local specialty business gives us opportunities for profitable growth throughout the insurance cycle. 

The Hiscox Group employs over 3,000 people in 13 countries, and has customers worldwide. Through the retail businesses in the USA, UK and Europe, we offer a range of specialist insurance products in commercial and personal lines. Internationally-traded, bigger-ticket business and reinsurance is underwritten through Hiscox London Market and Hiscox Re & ILS.

Our values define our business, with a focus on people, courage, ownership and integrity. We pride ourselves on being true to our word and our award-winning claims service is testament to that. For more information, visit www.hiscoxgroup.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBLBDGUUGDGUX
Date   Source Headline
2nd Jan 20255:40 pmRNSTotal Voting Rights
2nd Dec 20242:36 pmRNSTotal Voting Rights
26th Nov 20247:00 amRNSTR-1: Notification of major holdings
11th Nov 20248:00 amRNSSyndicates 33 and 6104 – results and estimates
8th Nov 20247:00 amRNSDirector/PDMR Shareholding
7th Nov 20247:00 amRNSQ3 2024 Trading Statement
1st Nov 20243:32 pmRNSTotal Voting Rights
1st Oct 20242:40 pmRNSTotal Voting Rights
27th Sep 202412:32 pmRNSDirector/PDMR Shareholding
20th Sep 20247:00 amRNSApplication to be Admitted to Official List
17th Sep 20243:35 pmRNSTR-1 Standard form - notification major holdings
12th Sep 20245:35 pmRNSAnnouncement of Scrip Reference Share Price
4th Sep 20247:00 amRNSTotal Voting Rights
2nd Sep 20247:00 amRNSAppointment - Jane Guyett to the Hiscox Ltd Board
23rd Aug 20247:00 amRNSHiscox Ltd confirms Interim Chair
22nd Aug 20244:32 pmRNSStatement regarding the death of Jonathan Bloomer
15th Aug 20247:01 amRNSCompletion of share repurchase programme
15th Aug 20247:00 amRNSTransaction in Own Shares
14th Aug 20247:00 amRNSTransaction in Own Shares
13th Aug 20247:00 amRNSTransaction in Own Shares
12th Aug 20249:47 amRNSSyndicates 33 and 6104 – results and estimates
12th Aug 20247:00 amRNSTransaction in Own Shares
9th Aug 20247:00 amRNSTransaction in Own Shares
8th Aug 20247:00 amRNSTransaction in Own Shares
7th Aug 20247:00 amRNSHiscox Ltd interim results
7th Aug 20247:00 amRNSTransaction in Own Shares
6th Aug 20247:00 amRNSTransaction in Own Shares
5th Aug 20244:43 pmRNSTotal Voting Rights
5th Aug 20247:00 amRNSTransaction in Own Shares
2nd Aug 20247:00 amRNSTransaction in Own Shares
1st Aug 20247:00 amRNSTransaction in Own Shares
31st Jul 20247:00 amRNSTransaction in Own Shares
30th Jul 20247:00 amRNSTransaction in Own Shares
29th Jul 20247:00 amRNSTransaction in Own Shares
26th Jul 20247:00 amRNSTransaction in Own Shares
25th Jul 20247:00 amRNSTransaction in Own Shares
24th Jul 20247:00 amRNSTransaction in Own Shares
23rd Jul 20247:00 amRNSTransaction in Own Shares
22nd Jul 20247:00 amRNSTransaction in Own Shares
19th Jul 202410:36 amRNSTransaction in Own Shares
18th Jul 20247:00 amRNSTransaction in Own Shares
17th Jul 20247:00 amRNSTransaction in Own Shares
16th Jul 20247:00 amRNSTransaction in Own Shares
15th Jul 20247:00 amRNSTransaction in Own Shares
12th Jul 20247:00 amRNSTransaction in Own Shares Replacement
11th Jul 20246:29 pmRNSTransaction in Own Shares
9th Jul 20247:00 amRNSTransaction in Own Shares
8th Jul 20247:00 amRNSTransaction in Own Shares
5th Jul 20247:00 amRNSTransaction in Own Shares
4th Jul 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.